MiR-34a and P53
Overview
Authors
Affiliations
MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4.
Wang Q, Selth L, Callen D Oncotarget. 2017; 8(18):29914-29924.
PMID: 28430625 PMC: 5444713. DOI: 10.18632/oncotarget.15530.
Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.
Samuel N, Wilson G, Said B, Pan A, Deblois G, Fischer N Oncotarget. 2016; 7(31):49611-49622.
PMID: 27391063 PMC: 5226533. DOI: 10.18632/oncotarget.10417.
The Role of miR-34a in Tritiated Water Toxicity in Human Umbilical Vein Endothelial Cells.
Cui F, Liu L, Zheng L, Bao G, Tu Y, Sun L Dose Response. 2016; 14(2):1559325816638585.
PMID: 27099602 PMC: 4822198. DOI: 10.1177/1559325816638585.
Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.
Li X, Jones M, Subramanian M, Lal A FEBS Lett. 2014; 588(16):2610-5.
PMID: 24726728 PMC: 6314029. DOI: 10.1016/j.febslet.2014.03.054.
Stankevicins L, Silva A, Ventura Dos Passos F, Dos Santos Ferreira E, Ribeiro M, David M Radiat Oncol. 2013; 8:231.
PMID: 24094113 PMC: 3829672. DOI: 10.1186/1748-717X-8-231.